Planning approval for our new Centre

We are delighted to announce that the University of SouthamptonÕs application to build the Centre for Cancer Immunology has been approved by Southampton City Council. The new world-leading research centre will be situated at Southampton General Hospital and is planned to open in 2017.

Planning consent granted for new Centre for Cancer Immunology

We are delighted to announce that the University of Southampton’s planning application to build the Centre for Cancer Immunology has been approved by Southampton City Council. Please read our full press release.

£4.5m grant for new Centre

The University of Southampton’s £25 million campaign to build a new cancer research centre is 75 per cent of the way to hitting its target thanks to a £4.5m grant from the Solent Local Enterprise Partnership (LEP).

New milestone on World Cancer Day

We are delighted to announce that our campaign is now three quarters of the way to hitting its £25m target, boosted by a £4.5m grant from the Solent Local Enterprise Partnership (LEP). Help us reach our target by texting ‘YOUREIT’ to 70660 to donate £3.

Close collaboration with BioInvent will develop innovative drugs to boost anti-cancer immunity in patients

BioInvent International (STO:BINV) announces that it has gained access to novel technology for making highly efficacious immune stimulatory antibodies to combat cancer. This initiative continues BioInvent’s long standing research collaborations with the University of Southampton. Read full article from the Business Wire.

Solent TV Ð interview with Professor Tim Elliott

Watch the latest interview with Professor Tim Elliott, the new Director for the planned Centre for Cancer Immunology, broadcast on ThatÕs Solent TV.

Front cover story in Journal of Immunology

This month’s prestigious Journal of Immunology features a large piece of collaborative work carried out by the University of Southampton’s Antibody and Vaccine Group within Cancer Sciences, as its cover story.

Dr Stephen Beers, Associate Professor in Cancer Immunology and Immunotherapy, explains the science behind the picture and why identifying special receptors on cells is key to designing better treatments to treat aggressive cancers.